A05-20C
Bupropion, mirtazapine, and reboxetine in the treatment of depression

Executive summary of final report (PDF, 280 KB)

Final report (PDF, 4.2 MB)(German version)
completion 09.11.2009
published 24.11.2009

Documentation and appraisal of comments on the preliminary report (PDF, 5.3 MB)(German version)
completion 09.11.2009
published 24.11.2009

Appendices to the documentation and appraisal of comments on the preliminary report: Information on studies of reboxetine


Executive summary of preliminary report (PDF, 231 KB)

Preliminary report (PDF, 1.7 MB) (German version)
completion 29.05.2009
published 10.06.2009

The deadline for submission of comments on the preliminary report for commission A05-20C was 09.07.2009 (4.00pm).


Report plan version 1.0 (PDF, 279 KB) (German version)
completion 26.09.2008
published 07.10.2008

Documentation and appraisal of comments on the report plan and amendment 1 (PDF, 1 MB)(German version)
completion 26.09.2008
published 07.10.2008


Amendment 1 to the report plan (PDF, 42 KB) (German version)
completion 07.05.2008
published 20.05.2008

The deadline for submission of comments on the amendment 1 was 17.06.2008 (16.00).


Report plan - preliminary version (PDF, 292 KB) (German version)
completion 12.12.2007
published 21.12.2007

The deadline for submission of comments on the report plan (preliminary version) for commission A05-20C was 25.01.2008, 16:00 pm.


The commission was awarded by the Federal Joint Committee on 22.02.2005.